Abstract
Two cases of refractory acute myeloid leukaemia were treated with methoxy-9-ellipticine lactate alone and in combination with other chemotherapeutic agents. In the first patient a successful complete second and third remission was achieved lasting 2 and 3 months respectively. However, a partial remission was obtained in the second patient as treatment with methoxy-9-ellipticine was only started in the terminal phase of the illness. In view of the resistance of this form of leukaemia to present chemotherapeutic drugs both initally and at the time of relapse, the response of these two cases to methoxy-9-ellipticine is worth reporting.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ansari B. M., Thompson E. N. Refractory leukemia treated with cytosine arabinoside and cyclophosphamide. Cancer. 1973 Aug;32(2):294–297. doi: 10.1002/1097-0142(197308)32:2<294::aid-cncr2820320203>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
- Crowther D., Bateman C. J., Vartan C. P., Whitehouse J. M., Malpas J. S., Fairley G. H., Scott R. B. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. Br Med J. 1970 Nov 28;4(5734):513–517. doi: 10.1136/bmj.4.5734.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garcia-Giralt E., Macieira-Coelho A. Methoxy-9-ellipticine. II. Analysis in vitro of the mechanism of action. Rev Eur Etud Clin Biol. 1970 May;15(5):539–541. [PubMed] [Google Scholar]
- Mathé G., Hayat M., De Vassal F., Schwarzenberg L., Schneider M., Schlumberger J. R., Jasmin C., Rosenfeld C. Methoxy-9-ellipticine lactate. 3. Clinical screening: its action in acute myeloblastic leukaemia. Rev Eur Etud Clin Biol. 1970 May;15(5):541–545. [PubMed] [Google Scholar]